[Using LAK cells in the adoptive immunotherapy in cancers].
D000818:Animals; D006801:Humans; D007116:Immunization, Passive / Q000379:methods*; D007376:Interleukin-2 / Q000627:therapeutic use; D007694:Killer Cells, Natural / Q000637:transplantation*; D051379:Mice; D009369:Neoplasms / Q000628:therapy*; D012513:Sarcoma, Experimental / Q000628:therapy
D007376:Interleukin-2